Home page  |  Help  |  Clear
English  |  French
 Search  |  Categories  |  Titles A-Z  |  Countries  |  Compare countries  |  Index  
Full TOC
Expand Document
Expand Chapter
Preferences

close this bookNational Drug Policy - Nigeria (FMOH, WHO; 2005; 32 pages)
View the documentFOREWORD
View the documentACKNOWLEDGEMENTS
View the documentACRONYMS
View the document1.0 INTRODUCTION
View the document2.0 DEFINITION
View the document3.0 GOALS OF THE NATIONAL DRUG POLICY
View the document4.0 OBJECTIVES OF THE NATIONAL DRUG POICY
View the document5.0. TARGETS OF THE NATIONAL DRUG POLICY
close this folder6.0 STRATEGIES FOR IMPLEMENTING THE NATIONAL DRUG POLICY
View the document6.1 SELECTION OF DRUGS
View the document6.2 PROCUREMENT OF DRUGS
View the document6.3 DRUG REVOLVING FUND SCHEME
View the document6.4 PRICING POLICY
View the document6.5 DRUG STORAGE
View the document6.6 DRUG DISTRIBUTION
Open this folder and view contents6.7 RATIONAL DRUG USE
View the document6.8 DONATED DRUGS
View the document6.9 LOCAL DRUG PRODUCTION
View the document6.10 LEGISLATION
View the document6.11 INSPECTION OF DRUGS
View the document6.12 IMPORTATION AND EXPORTATION OF DRUGS
View the document6.13 REGISTRATION OF DRUGS
View the document6.14 PATENTS
View the document6.15 QUALITY ASSURANCE
Open this folder and view contents6.16 REGULATIONS FOR PRESCRIBING AND DISPENSING DRUGS
View the document6.17 PHARMACOVIGILANCE
View the document6.18 DRUG INFORMATION AND PROMOTION
View the document6.19 DRUG FINANCING AND AFFORDABILITY
Open this folder and view contents6.20 RESEARCH AND DEVELOPMENT
View the document6.21 HERBAL AND OTHER TRADITIONAL REMEDIES
View the document6.22 HUMAN RESOURCES DEVELOPMENT
View the document6.23 CONTROL OF VETERINARY DRUGS
View the document6.24 INTERNATIONAL COOPERATION
View the document6.25 MONITORING AND EVALUATION
 

6.9 LOCAL DRUG PRODUCTION

The need for increased capacity in local drug production has been well recognised. Such capacity should cover the production of raw materials and intermediate products, not just formulation and packaging. Drug production facilities in the country are presently operating under severe constraints, including the following:

• poor infrastructural facilities such as water and electricity supply,
• poor transportation and communication,
• poor waste disposal management,
• inadequate incentives such as tax relief, capital allowance, and government patronage
• limited access to funds for capital development,
• unfair competition by imported drugs, and
• reliance on imported raw materials, machinery and spare parts.


In order to achieve the target of greater reliance on local drug production, steps shall be taken by government to:

i. Encourage the development of a stable economic and political environment;

ii. Intensify efforts to improve basic infrastructure and facilities;

iii. Provide an efficient regulatory environment;

iv. Provide favourable tax, interest rate regime and duty structures for locally manufactured products and imported raw materials, as well as for drug packaging materials;

v. Intensify efforts to ensure that the petrochemical and other essential industries for the proper development of the pharmaceutical manufacturing industry come on stream;

vi. Encourage research on pharmaceutical raw materials;

vii. Promote the development of associated industries for the production of materials, such as plastics, glass, paper, aluminium foil, etc., which are essential for drug packaging;

viii. Encourage patronage of local drug manufacturers by public and private health care institutions;

ix. Provide grants for the establishment of plants for the production of basic raw materials.

x. Encourage small-scale pharmaceutical production.

to previous sectionto next section

Please provide your feedback English  |  French